Uncovering the Molecular Mechanism of A Novel Near-infrared Fluorescence Imaging Drug Caba-780 in Bladder Cancer

To investigate the molecular mechanism by which Caba-780 inhibits the progression of bladder cancer, we treated bladder cancer cells with Caba-780 for 24 hours We then used RNA-seq data from T-24 cells for gene expression profiling Compare the gene expression profiles of RNA-seq data from control group and administration group of T24 cells.